Report Code: A13855 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Biopharma cold chain product is defined as any temperature-sensitive substance, such as frozen foods, blood components, stem cells, tissues, cells, vaccines, and infectious substances, which involves safe packaging to endure cold temperatures of the storage containers during transportation. Secure packaging ensures the sterility, safety, and viability of the biopharma products and specimen inside.Â
Cold chain packaging uses active and passive packaging methods. Active packaging comprises leased containers that employ a power source and a thermostat to control heating or cooling inside the shipping container. Conversely, passive packaging configurations are manufactured containers that utilize insulated packaging such as polyurethane, polystyrene, or vacuum insulated panels and phase change materials (PCM) to sustain a desired temperature within the shipping container.
COVID-19 Impact Analysis
Top Impacting Factors
Changing lifestyle of people, growing population, and rapid urbanization in emerging economies are triggering consumers to opt for processed and easy-to-eat food items. The requirement for efficient packaging and transportation solutions in the biopharmaceutical industries primarily drives the biopharma cold chain packaging market growth.
Stringent government regulations (mandate the use of high barrier packaging materials and sealants for several liquid drugs) for the packaging of biopharma products are impacting the market positively.Â
Governments in developing countries are continuously upgrading their industry standards for packaging to maintain quality, safety, and to reduce breakage/spillage and contamination. This trend is likely to boost the demand for the advanced biopharma chain packaging market.
An increase in the development of more complex biological-based medicines and shipments of vaccines, hormone treatments, and complex proteins that require cold chain refinements to be transported at a controlled temperature has increased the demand for biopharma cold chain packaging market.
However, high cost associated with cold chain packaging is expected to restrain the biopharma cold chain packaging market growth.
Market Trends
New product launches to flourish the market
Surge in usage to pack temperature-sensitive pharmaceutical products
Key Benefits of the Report
Questions Answered in the Biopharma Cold Chain Packaging Report
Biopharma Cold Chain Packaging Market Report Highlights
Aspects | Details |
---|---|
By Product Type |
|
By Application |
|
By End User |
|
By Region |
|
Key Market Players | Softbox systems, Sofrigam, Cascades Inc, Intelsius, Pelican Products, Inc, Sonoco ThermoSafe, va-Q-tec., Creopack, Cryopak A TCP Company, Cold Chain Technologies |
Loading Table Of Content...
Start reading.
This Report and over 71,321+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers